Despite a variety of hypotheses considering potential factors and risks in the pathogenesis of MDD, nearly all of the hypotheses can be considered in the context of the GSK3β activity, which places the kinase at a central point of depression development and treatment. The gene discussed is GSK3B; the disease is depressive symptom measurement.